419460005: Nepafenac (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Substance with prostaglandin-endoperoxide synthase inhibitor mechanism of action (substance)\...

\Cyclooxygenase-1 inhibitor\Nepafenac (substance)

\Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance)\Nepafenac (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Substance with prostaglandin-endoperoxide synthase inhibitor mechanism of action (substance)\Cyclooxygenase-1 inhibitor\Nepafenac (substance)
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Substance with prostaglandin-endoperoxide synthase inhibitor mechanism of action (substance)\Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance)\Nepafenac (substance)
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Analgesic (substance)\Non-opioid analgesic (substance)\Non-steroidal anti-inflammatory agent (substance)\Cyclooxygenase-1 inhibitor\Nepafenac (substance)
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Analgesic (substance)\Non-opioid analgesic (substance)\Non-steroidal anti-inflammatory agent (substance)\Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance)\Nepafenac (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Amide\Nepafenac (substance)

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Amide\Nepafenac (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2006. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Nepafenac (substance)	Is a	Non-steroidal anti-inflammatory agent (substance)	false	Inferred relationship	Some
Nepafenac (substance)	Is a	agent ophtalmique	false	Inferred relationship	Some
Nepafenac (substance)	Is a	Cyclooxygenase-1 inhibitor	true	Inferred relationship	Some
Nepafenac (substance)	Is a	Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance)	true	Inferred relationship	Some
Nepafenac (substance)	Is a	Amide	true	Inferred relationship	Some
Nepafenac (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Cyclooxygenase-2 inhibitor	true	Inferred relationship	Some
Nepafenac (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Cyclooxygenase-1 inhibitor	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing nepafenac (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Nepafenac (substance)	Inferred relationship	Some	1
Product containing precisely nepafenac 1 milligram/1 milliliter conventional release eye suspension (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Nepafenac (substance)	Inferred relationship	Some
Nepafenac only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Nepafenac (substance)	Inferred relationship	Some	1
Product containing precisely nepafenac 1 milligram/1 milliliter conventional release eye suspension (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Nepafenac (substance)	Inferred relationship	Some	1
Product containing precisely nepafenac 1 milligram/1 milliliter conventional release eye suspension (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Nepafenac (substance)	Inferred relationship	Some	1
Nepafenac-containing product in ocular dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Nepafenac (substance)	Inferred relationship	Some	1
Product containing only nepafenac in ocular dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Nepafenac (substance)	Inferred relationship	Some	1
Product containing precisely nepafenac 1 milligram/1 milliliter conventional release eye drops (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Nepafenac (substance)	Inferred relationship	Some	1
Product containing precisely nepafenac 1 milligram/1 milliliter conventional release eye drops (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Nepafenac (substance)	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
2574918015	Nepafenac (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2578346019	Nepafenac	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
369431000195114	nepafenac	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
192081000077117	népafénac	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
2410511000195118	Nepafenac	de	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module